Clinical Trial Update: Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS) [Phase 4]

View source ↗

Summary

This update notes the completion of a Phase 4 clinical trial evaluating controlled-release paroxetine for treating Irritable Bowel Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Duke University | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED